These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10076609)

  • 1. Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model.
    Matsumoto G; Sunamura M; Shimamura H; Kodama T; Hashimoto W; Kobari M; Kato K; Takeda K; Yagita H; Okumura K; Hamada H; Matsuno S
    Surgery; 1999 Mar; 125(3):257-64. PubMed ID: 10076609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells.
    Lechanteur C; Moutschen M; Princen F; Lopez M; Franzen E; Gielen J; Bours V; Merville MP
    Cancer Gene Ther; 2000 May; 7(5):676-82. PubMed ID: 10830715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
    Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.
    Zitvogel L; Tahara H; Robbins PD; Storkus WJ; Clarke MR; Nalesnik MA; Lotze MT
    J Immunol; 1995 Aug; 155(3):1393-403. PubMed ID: 7636204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
    Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
    J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
    Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
    J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of anti-tumor immunity by injection of fibroblasts genetically engineered to produce IL-12 and to express CD70.
    Douin-Echinard V; Robbins PD; Lotze MT; Favre G; Couderc B
    Adv Exp Med Biol; 1998; 451():353-7. PubMed ID: 10026896
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12.
    Fuji N; Fujiwara H; Ueda Y; Taniguchi F; Yoshimura T; Oka T; Yamagishi H
    Gene Ther; 1999 Jun; 6(6):1120-7. PubMed ID: 10455415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
    Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
    Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor and antimetastatic activity of IL-23.
    Lo CH; Lee SC; Wu PY; Pan WY; Su J; Cheng CW; Roffler SR; Chiang BL; Lee CN; Wu CW; Tao MH
    J Immunol; 2003 Jul; 171(2):600-7. PubMed ID: 12847224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.
    Hess SD; Egilmez NK; Shiroko J; Bankert RB
    Cancer Gene Ther; 2001 May; 8(5):371-7. PubMed ID: 11477457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
    Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
    Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma].
    Patry Y; Meflah K; Le Pendu J
    Bull Cancer; 1996 Mar; 83(3):218-26. PubMed ID: 8695924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases.
    Sabel MS; Hill H; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Surgery; 2001 Sep; 130(3):470-8. PubMed ID: 11562672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.